Early detection of prostate cancer: is screening in general practice justifiable?
作者信息
Sigurdsson Emil L
出版信息
Scand J Prim Health Care. 2011 Sep;29(3):133-4. doi: 10.3109/02813432.2011.602555. Epub 2011 Aug 16.
Abstract
摘要
相似文献
1
Early detection of prostate cancer: is screening in general practice justifiable?前列腺癌的早期检测：全科医疗中的筛查是否合理？
Scand J Prim Health Care. 2011 Sep;29(3):133-4. doi: 10.3109/02813432.2011.602555. Epub 2011 Aug 16.
2
Re: prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up.关于：在随机化前列腺、肺、结肠直肠和卵巢癌筛查试验中的前列腺癌筛查：13年随访后的死亡率结果
J Natl Cancer Inst. 2012 May 16;104(10):793; author reply 793-4. doi: 10.1093/jnci/djs205. Epub 2012 Apr 5.
3
Screening for prostate cancer remains controversial.前列腺癌筛查仍然存在争议。
Lancet. 2009 Oct 31;374(9700):1482-3. doi: 10.1016/S0140-6736(09)61085-0. Epub 2009 Aug 5.
4
Study Finds Overall Prostate Cancer Mortality Decreases with PSA Screening.研究发现前列腺癌总体死亡率随前列腺特异性抗原筛查而降低。
Am J Nurs. 2017 Dec;117(12):16. doi: 10.1097/01.NAJ.0000527472.38965.1f.
5
Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).欧洲前列腺癌筛查随机研究（ERSPC）中分期变化与死亡率差异之间的相关性。
BJU Int. 2016 Nov;118(5):677-680. doi: 10.1111/bju.13505. Epub 2016 May 20.
6
[Prostate cancer screening: no proof of the benefit].[前列腺癌筛查：尚无益处的确凿证据]
Presse Med. 2009 Oct;38(10):1393-5. doi: 10.1016/j.lpm.2009.07.001. Epub 2009 Aug 3.
7
Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.前列腺癌筛查与死亡率：近期随机对照临床试验的比较
Urol Oncol. 2010 May-Jun;28(3):233-6. doi: 10.1016/j.urolonc.2009.11.011. Epub 2010 Jan 25.
8
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.使用前列腺特异性抗原（PSA）检测进行前列腺癌筛查：临床实践指南。
BMJ. 2018 Sep 5;362:k3581. doi: 10.1136/bmj.k3581.
9
Screening for prostate cancer remains controversial.前列腺癌筛查仍然存在争议。
BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601.
10
Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?用于前列腺癌早期检测的血清前列腺特异性抗原：总是有用、从不有用还是有时有用？
J Clin Oncol. 2011 Feb 1;29(4):345-7. doi: 10.1200/JCO.2010.32.5308. Epub 2010 Dec 28.
引用本文的文献
1
Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs.丹麦全科医生在前列腺癌机会性筛查中对前列腺特异性抗原的使用：一项涵盖174名全科医生的调查。
Int J Family Med. 2013;2013:540707. doi: 10.1155/2013/540707. Epub 2013 Nov 19.
2
Milestones in the development of Nordic general practice*.北欧全科医学发展的里程碑*。
Scand J Prim Health Care. 2013 Mar;31(1):3-5. doi: 10.3109/02813432.2012.762163. Epub 2013 Jan 22.
本文引用的文献
1
Randomised prostate cancer screening trial: 20 year follow-up.随机前列腺癌筛查试验：20 年随访。
BMJ. 2011 Mar 31;342:d1539. doi: 10.1136/bmj.d1539.
2
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.前列腺癌筛查：随机对照试验的系统评价和荟萃分析。
BMJ. 2010 Sep 14;341:c4543. doi: 10.1136/bmj.c4543.
3
Informed participation in cancer screening: the facts are changing, and GPs are going to feel it.癌症筛查中的知情参与：情况正在发生变化，全科医生将会感受到这一点。
Scand J Prim Health Care. 2010 Mar;28(1):1-3. doi: 10.3109/02813431003625410.
4
Early diagnosis of cancer--the role of general practice.癌症的早期诊断——全科医疗的作用
Scand J Prim Health Care. 2009;27(4):193-4. doi: 10.3109/02813430903478623.
5
Screening for prostate cancer remains controversial.前列腺癌筛查仍然存在争议。
BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601.
6
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
7
Mortality results from a randomized prostate-cancer screening trial.一项前列腺癌随机筛查试验的死亡率结果。
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18.
8
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.前列腺特异性抗原筛查中的提前期和过度诊断：方法及背景的重要性
J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. doi: 10.1093/jnci/djp001. Epub 2009 Mar 10.
9
Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.前列腺特异性抗原筛查前列腺癌的利弊：美国预防服务工作组的证据更新
Ann Intern Med. 2008 Aug 5;149(3):192-9. doi: 10.7326/0003-4819-149-3-200808050-00009.
10
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.解读北欧五国前列腺癌发病率和死亡率的趋势。
J Natl Cancer Inst. 2007 Dec 19;99(24):1881-7. doi: 10.1093/jnci/djm249. Epub 2007 Dec 11.
Zotero 插件